Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study)

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Sundqvist Pernilla) > Use of venous-throm...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		05006naa a2200541 4500
001		oai:DiVA.org:oru-70045
003		SwePub
008		181107s2018 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
009		oai:DiVA.org:umu-153842
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-700452 URI
024	7	a https://doi.org/10.2147/RRU.S1777742 DOI
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1538422 URI
040		a (SwePub)orud (SwePub)umu
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Lund, Larsu Department of Urology, Odense University Hospital, Odense, Denmark; Clinical Institute, Southern University of Denmark, Odense, Denmark4 aut
245	1 0	a Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors :b a questionnaire survey in the Nordic countries (The NORENCA-2 study)
264	1	b DOVE Medical Press Ltd.c 2018
338		a print2 rdacarrier
500		a Funding Agency:Scandinavian Association of Urology
520		a Purpose: To examine the variation in venous thromboembolism prophylactic treatment (VTEP) among renal cancer patients undergoing surgery.Materials and methods: An Internet-based questionnaire on renal tumor management before and after surgery was mailed to all Nordic departments of urology. The questions focused on the use of VTEP and were subdivided into different surgical modalities.Results: Questionnaires were mailed to 91 institutions (response rate 53%). None of the centers used VTEP before surgery, unless the patient had a vena caval tumor thrombus. Overall, the VTEP utilized during hospitalization for patients undergoing renal surgery included early mobilization (45%), compression stockings (52%) and low-molecular-weight heparin (89%). In patients undergoing open radical Nx, 80% of institutions used VTEP during their hospitalization (23% compression stockings and 94% low-molecular-weight heparin). After leaving the hospital, the proportion and type of VTEP received varied considerably across institutions. The most common interval, used in 60% of the institutions, was for a period of 4 weeks. The restriction to the Nordic countries was a limitation and, therefore, may not reflect the practice patterns elsewhere. It is a survey study and, therefore, cannot measure the behaviors of those institutions that did not participate.Conclusion: We found variation in the type and duration of VTEP use for each type of local intervention for renal cancer. These widely disparate variations in care strongly argue for the establishment of national and international guidelines regarding VTEP in renal surgery.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng
653		a venous-thrombotic-embolic prophylaxis kidney cancer
653		a surgery
653		a nephrectomy
653		a mortality
653		a complication
653		a minimally invasive methods
653		a thrombosis prophylaxis
700	1	a Nisen, Harryu Department of Urology, Helsinki University Hospital, Helsinki, Finland4 aut
700	1	a Järvinen, Petrusu Department of Urology, Helsinki University Hospital, Helsinki, Finland4 aut
700	1	a Fovaeus, Magnusu Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden4 aut
700	1	a Gudmundson, Eirikuru Department of Urology, Landspitali University Hospital, Reykjavik, Iceland4 aut
700	1	a Kromann-Andersen, Bjarneu Department of Urology, Herlev University Hospital, Copenhagen, Denmark4 aut
700	1	a Ljungberg, Börje,d 1949-u Umeå universitet,Urologi och andrologi4 aut0 (Swepub:umu)bolj0001
700	1	a Nilsen, Frodeu Department of Urology, Akershus University Hospital, Lörenskog, Norway4 aut
700	1	a Sundqvist, Pernilla,d 1973-u Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Urology4 aut0 (Swepub:oru)pst
700	1	a Clark, Peter E.u Department of Urology, Atrium Health, Charlotte NC, USA4 aut
700	1	a Beisland, Christianu Department of Urology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway4 aut
710	2	a Department of Urology, Odense University Hospital, Odense, Denmark; Clinical Institute, Southern University of Denmark, Odense, Denmarkb Department of Urology, Helsinki University Hospital, Helsinki, Finland4 org
773	0	t Research and Reports in Urologyd : DOVE Medical Press Ltd.g 10, s. 181-187q 10<181-187x 2253-2447
856	4	u https://doi.org/10.2147/RRU.S177774y Fulltext
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70045
856	4 8	u https://doi.org/10.2147/RRU.S177774
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-153842

Hitta via bibliotek

Research and Reports in Urology (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Lund, Lars; Nisen, Harry; Järvinen, Petrus; Fovaeus, Magnus; Gudmundson, Eiri ...; Kromann-Andersen ...; visa fler...; Ljungberg, Börje ...; Nilsen, Frode; Sundqvist, Perni ...; Clark, Peter E.; Beisland, Christ ...; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Urologi och njur ...

Artiklar i publikationen: Research and Rep ...

Av lärosätet: Örebro universitet; Umeå universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se